Arvinas Announces Oversubscribed $350 Million Private Placement NEW HAVEN, Conn., Nov. 27, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Cleerly, Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at AHA 2023 Cleerly, Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023 Data from randomized...
Bluesight Appoints Jason Vander Meer as Chief Product Officer to Expand Medication Intelligence Suite New leader of product strategy and development to drive innovation, support company’s growth plans ALEXANDRIA, Va., Oct. 26, 2023 — Bluesight, the leader in...
HARPOON THERAPEUTICS ANNOUNCES UP TO $150 MILLION PRIVATE PLACEMENT SOUTH SAN FRANCISCO, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP) (the “Company”), a clinical-stage immunotherapy company developing novel T cell engagers,...
Kalderos names veteran healthcare leader Angie Franks as new CEORedefining how the business of healthcare performs.™ (PRNewsfoto/Kalderos) Experienced chief executive brings growth mindset,strong vision to Drug Discount Management solution leader CHICAGO, Sept. 20,...
Recent Comments